[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Next Issue
Volume 5, September
Previous Issue
Volume 5, July
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 

Toxins, Volume 5, Issue 8 (August 2013) – 12 articles , Pages 1332-1502

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
485 KiB  
Review
Immunotoxins: The Role of the Toxin
by Antonella Antignani and David FitzGerald
Toxins 2013, 5(8), 1486-1502; https://doi.org/10.3390/toxins5081486 - 21 Aug 2013
Cited by 103 | Viewed by 16088
Abstract
Immunotoxins are antibody-toxin bifunctional molecules that rely on intracellular toxin action to kill target cells. Target specificity is determined via the binding attributes of the chosen antibody. Mostly, but not exclusively, immunotoxins are purpose-built to kill cancer cells as part of novel treatment [...] Read more.
Immunotoxins are antibody-toxin bifunctional molecules that rely on intracellular toxin action to kill target cells. Target specificity is determined via the binding attributes of the chosen antibody. Mostly, but not exclusively, immunotoxins are purpose-built to kill cancer cells as part of novel treatment approaches. Other applications for immunotoxins include immune regulation and the treatment of viral or parasitic diseases. Here we discuss the utility of protein toxins, of both bacterial and plant origin, joined to antibodies for targeting cancer cells. Finally, while clinical goals are focused on the development of novel cancer treatments, much has been learned about toxin action and intracellular pathways. Thus toxins are considered both medicines for treating human disease and probes of cellular function. Full article
(This article belongs to the Special Issue Toxins and Carcinogenesis)
Show Figures

Figure 1

Figure 1
<p>Graphic representations of three toxins, diphtheria toxin (DT), <span class="html-italic">Pseudomonas</span> exotoxin (PE) and the plant toxin, ricin. Above each “domain” is a functional label. Below each domain is a common name that was used in early publications. DT has an <span class="html-italic">N</span>-terminus catalytic domain (C-domain) also known and the A fragment followed by a protease processing site, then a nine helix domain (commonly known as the “T” or translocation-domain) followed by a receptor binding domain (R-domain). The B-fragment includes both the T-domain and the R-domain. PE has an <span class="html-italic">N</span>-terminal receptor-binding domain followed by a processing domain. Then at the <span class="html-italic">C</span>-terminus there is a catalytic domain followed by a KDEL-like sequence. Ricin has a catalytic domain at the <span class="html-italic">N</span>-terminus, followed by a processing site and then a duplicated receptor-binding domain with a preference for binding galactose residues. Each toxin has a helical domain where several helices follow in close sequence. For DT there are nine helices while PE has 6; and these helices are arranged in what appears to be a separate domain between C and R-domains. Ricin also has a cluster of helices but these are located in the middle of its catalytic domain. A simple view of these helical domains is that they function in the translocation of each toxin’s C-domain. However, this has only been established for the T-domain of DT. The site of proteolytic processing is shown for each toxin.</p>
Full article ">Figure 2
<p>Immunotoxin construction-from oldest to newest. First generation immunotoxins were constructed by using chemical crosslinking agents to attach intact toxins to intact antibodies. Second generation immunotoxins used modified toxins lacking receptor-binding domains. Third generation molecules used cloned antibody fragments fused to modified toxin genes; allowing for the recombinant production of homogeneous protein. Further improvements of the third generation molecule might include the removal of immunogenic amino acids including (as shown) much of the multi-helical domain of PE.</p>
Full article ">
278 KiB  
Article
Effects of Decreased Vitamin D and Accumulated Uremic Toxin on Human CYP3A4 Activity in Patients with End-Stage Renal Disease
by Masayuki Tsujimoto, Yui Nagano, Satomi Hosoda, Asuka Shiraishi, Ayaka Miyoshi, Shima Hiraoka, Taku Furukubo, Satoshi Izumi, Tomoyuki Yamakawa, Tetsuya Minegaki and Kohshi Nishiguchi
Toxins 2013, 5(8), 1475-1485; https://doi.org/10.3390/toxins5081475 - 19 Aug 2013
Cited by 17 | Viewed by 6915
Abstract
In patients with end-stage renal disease, not only renal clearance but also hepatic clearance is known to be impaired. For instance, the concentration of erythromycin, a substrate of cytochrome P450 3A4 (CYP3A4), has been reported to be elevated in patients with end-stage renal [...] Read more.
In patients with end-stage renal disease, not only renal clearance but also hepatic clearance is known to be impaired. For instance, the concentration of erythromycin, a substrate of cytochrome P450 3A4 (CYP3A4), has been reported to be elevated in patients with end-stage renal disease. The purpose of this study is to elucidate the reason for the decrease in hepatic clearance in patients with end-stage renal disease. Deproteinized pooled sera were used to assess the effects of low-molecular-weight uremic toxins on CYP3A4 activity in human liver microsomes and human LS180 cells. Four uremic toxins (3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, hippuric acid, indole-3-acetic acid, and 3-indoxyl sulfate) present at high concentrations in uremic serum were also studied. Simultaneous treatment of uremic serum (less than 10%) or uremic toxins did not affect testosterone 6?-hydroxylation in human liver microsomes. On the other hand, pretreatment of each serum activates CYP3A4 in LS180 cells, and the increased CYP3A4 activity in uremic serum-treated cells was smaller than normal serum-treated cells. In addition, CYP3A4 and CYP24A1 mRNA levels also increased in LS180 cells exposed to normal serum, and this effect was reduced in uremic serum-treated cells and in cells exposed to uremic serum added to normal serum. Furthermore, addition of 1,25-dihydroxyvitamin D to uremic serum partially restored the serum effect on CYP3A4 expression. The present study suggests that the decrease of 1,25-dihydroxyvitamin D and the accumulation of uremic toxins contributed to the decreased hepatic clearance of CYP3A4 substrates in patients with end-stage renal disease. Full article
(This article belongs to the Special Issue Uremic Toxins)
Show Figures

Figure 1

Figure 1
<p>The effects of uremic serum on testosterone 6β-hydroxylation in human liver microsomes. The reaction was performed in human liver microsomes (0.1 mg protein/mL) with a nicotinamide adenine dinucleotide phosphate (NADPH)-generating system and testosterone (50 µM) at 37 °C for 20 min in the presence of normal (NS: open column) or uremic (US: closed column) serum (1%, 3%, 10%). Each column represents the mean ± S.E. of 3 or 4 determinations.</p>
Full article ">Figure 2
<p>The effects of uremic toxins on testosterone 6β-hydroxylation in human liver microsomes. The reaction was performed in human liver microsomes (0.1 mg protein/mL) with a nicotinamide adenine dinucleotide phosphate (NADPH)-generating system and testosterone (50 µM) at 37 °C for 20 min in the absence or presence of CMPF (<b>A</b>), 3-Indoxyl sulfate (<b>B</b>), Indole-3-acetic acid (<b>C</b>), and Hippuric acid (<b>D</b>) (3, 10, 30, 100, and 300 µM). Each column represents the mean ± S.E. of 3 or 4 determinations. These controls were 8.83–10.85 pmol/min/mg protein.</p>
Full article ">Figure 3
<p>The effects of uremic serum and uremic toxins on CYP3A4 activity in LS180 cells. LS180 cells were seeded at 5 × 10<sup>4</sup> cells/mL in 24-well plates and cultivated for 4 days. After that, cells were incubated normal serum, uremic serum, or normal serum containing 4 uremic toxins (3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), 3-indoxyl sulfate, indole-3-acetic acid, and hippuric acid) for 24 h. Each point represents the mean ± S.E. (<span class="html-italic">n</span> = 4) of P450-GloTMAssays in LS180 cells. Significant differences between the mean values were determined by analysis of variance (ANOVA) followed by Tukey-Kramer test (** <span class="html-italic">p</span> &lt; 0.01). CYP3A4: cytochrome P450 3A4.</p>
Full article ">Figure 4
<p>The effects of uremic serum on CYP3A4, MDR1, and CYP24A1 mRNA expression levels in LS180 cells. LS180 cells were seeded at 5 × 10<sup>5</sup> cells/5 mL into 60 mm dishes and cultivated for 4 days. After that, the cells were treated with normal serum or uremic serum. Cytochrome P450 3A4 (CYP3A4) (<b>A</b>), multidrug resistance protein 1 (MDR1) (<b>B</b>), and CYP24A1 (<b>C</b>) mRNA expression levels were quantified by real-time reverse transcriptase (RT)-PCR. Each point represents the mean ± S.E. (<span class="html-italic">n</span> = 3). Significant differences between normal serum and uremic serum were determined by unpaired Student’s t-test (** <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 5
<p>The effects of 1,25-dihydroxyvitamin D and uremic toxins on CYP3A4 mRNA expression levels. LS180 cells were seeded at 5 × 10<sup>5</sup> cells/5 mL in 60-mm dishes and cultivated for 4 days. The cells were then treated with normal serum, uremic serum, uremic serum containing 1,25-dihydroxyvitamin D, normal serum containing 4 uremic toxins (3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), 3-indoxyl sulfate, indole-3-acetic acid, and hippuric acid) (<b>A</b>) or normal serum containing single uremic toxin (<b>B</b>). Cytochrome P450 3A4 (CYP3A4) mRNA expression levels were quantified by real-time RT-PCR. Each point represents the mean ± S.E. (<span class="html-italic">n</span> = 3). Significant differences between the mean values were determined by analysis of variance (ANOVA) followed by Tukey-Kramer test (** <span class="html-italic">p</span> &lt; 0.01, N.S.: not significant).</p>
Full article ">
561 KiB  
Review
The Cytotoxic Necrotizing Factor 1 from E. Coli: A Janus Toxin Playing with Cancer Regulators
by Alessia Fabbri, Sara Travaglione, Giulia Ballan, Stefano Loizzo and Carla Fiorentini
Toxins 2013, 5(8), 1462-1474; https://doi.org/10.3390/toxins5081462 - 14 Aug 2013
Cited by 34 | Viewed by 8920
Abstract
Certain strains of Escherichia coli have been indicated as a risk factor for colon cancer. E. coli is a normal inhabitant of the human intestine that becomes pathogenic, especially in extraintestinal sites, following the acquisition of virulence factors, including the protein toxin CNF1. [...] Read more.
Certain strains of Escherichia coli have been indicated as a risk factor for colon cancer. E. coli is a normal inhabitant of the human intestine that becomes pathogenic, especially in extraintestinal sites, following the acquisition of virulence factors, including the protein toxin CNF1. This Rho GTPases-activating toxin induces dysfunctions in transformed epithelial cells, such as apoptosis counteraction, pro-inflammatory cytokines’ release, COX2 expression, NF-kB activation and boosted cellular motility. As cancer may arise when the same regulatory pathways are affected, it is conceivable to hypothesize that CNF1-producing E. coli infections can contribute to cancer development. This review focuses on those aspects of CNF1 related to transformation, with the aim of contributing to the identification of a new possible carcinogenic agent from the microbial world. Full article
(This article belongs to the Special Issue Toxins and Carcinogenesis)
Show Figures

Figure 1

Figure 1
<p>Mechanism of action of CNF1. CNF1 is a single chain multidomain protein toxin that contains a binding domain at the <span class="html-italic">N</span>-terminus, a central translocation domain, and an enzymatic domain at <span class="html-italic">C</span>-terminus. CNF1 exerts its deamidating activity on a glutamine residue located in the switch 2 domain of the Rho GTPases, essential for the molecule inactivation by GTP hydrolysis. CNF1, by modifying glutamine into glutamic acid, stabilizes the G proteins in their GTP-bound active form enabling them to exert a permanent activity on their effectors. By activating these GTPase, CNF1 stimulates the actin cytoskeleton, fostering a prominent ruffling activity. The activated Rho GTPases are subsequently recognized for ubiquitylation and degraded in the proteasome.</p>
Full article ">Figure 2
<p>Signalling pathways triggered by CNF1-promoted Rho activation differ depending on the cell type. (<b>A</b>) In CNF1-challenged transformed cells, NF-kB translocates from cytoplasm to nucleus where it leads to the expression of pro-inflammatory and anti-apoptotic factors. Modulation of the actin cytoskeleton via the CNF1-activated Rho GTPases also plays a crucial role in certain aspects of the malignant phenotype. In particular, CNF1 induces: tumour cell motility, modification of cellular shape, loss of adhesion with consequent invasiveness and metastasis, an asymmetric cell division and aneuploidy. Furthermore, CNF1 provokes mitochondrial release of reactive oxygen species (ROS) with consequent pro-inflammatory cytokines expression. (<b>B</b>) In primary brain cells, through a cytoskeleton modulation, CNF1 acts on mitochondrial activity, boosts cellular ATP content, decreases pro-inflammatory cytokines expression, and increments synaptic plasticity. This leads, <span class="html-italic">in vivo</span>, to an enhancement of brain functional performances.</p>
Full article ">
259 KiB  
Article
Non-Linear Relationships between Aflatoxin B1 Levels and the Biological Response of Monkey Kidney Vero Cells
by Reuven Rasooly, Bradley Hernlem, Xiaohua He and Mendel Friedman
Toxins 2013, 5(8), 1447-1461; https://doi.org/10.3390/toxins5081447 - 14 Aug 2013
Cited by 13 | Viewed by 7570
Abstract
Aflatoxin-producing fungi contaminate food and feed during pre-harvest, storage and processing periods. Once consumed, aflatoxins (AFs) accumulate in tissues, causing illnesses in animals and humans. Most human exposure to AF seems to be a result of consumption of contaminated plant and animal products. [...] Read more.
Aflatoxin-producing fungi contaminate food and feed during pre-harvest, storage and processing periods. Once consumed, aflatoxins (AFs) accumulate in tissues, causing illnesses in animals and humans. Most human exposure to AF seems to be a result of consumption of contaminated plant and animal products. The policy of blending and dilution of grain containing higher levels of aflatoxins with uncontaminated grains for use in animal feed implicitly assumes that the deleterious effects of low levels of the toxins are linearly correlated to concentration. This assumption may not be justified, since it involves extrapolation of these nontoxic levels in feed, which are not of further concern. To develop a better understanding of the significance of low dose effects, in the present study, we developed quantitative methods for the detection of biologically active aflatoxin B1 (AFB1) in Vero cells by two independent assays: the green fluorescent protein (GFP) assay, as a measure of protein synthesis by the cells, and the microculture tetrazolium (MTT) assay, as a measure of cell viability. The results demonstrate a non-linear dose-response relationship at the cellular level. AFB1 at low concentrations has an opposite biological effect to higher doses that inhibit protein synthesis. Additional studies showed that heat does not affect the stability of AFB1 in milk and that the Vero cell model can be used to determine the presence of bioactive AFB1 in spiked beef, lamb and turkey meat. The implication of the results for the cumulative effects of low amounts of AFB1 in numerous foods is discussed. Full article
(This article belongs to the Special Issue Advances in Toxin Detection)
Show Figures

Figure 1

Figure 1
<p>Increase in tetrazolium salt (MTT) reduction (<b>A</b>) and green fluorescent protein (GFP) expression (<b>B</b>) in Vero cells in the presence of low concentrations of aflatoxin B<sub>1 </sub>(AFB1). Vero cells (<b>A</b>) and Vero cells transduced with Ad-CMV-GFP (<b>B</b>) were treated with increasing concentration of AFB1. The MTT reduction was colorimetrically measured, and GFP expression was quantified fluorometrically. Error bars represent standard errors (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 2
<p>Detection of AFB1 in milk. Nonfat dry milk was spiked with AFB1 at 1 and 20 μM. Five microliters of unheated or thermally-treated spiked milk with 95 μL of media were pre-incubated for 48 h in Vero cells. The cells were then transduced with Ad-CMV-GFP for 48 h. GFP expression was quantified fluorometrically, with the plot showing relative fluorescence units (RFU). Error bars represent standard errors (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 3
<p>Detection of AFB1 in meat. Beef, lamb and turkey were spiked with AFB1 at a concentration of 20 μM. Five microliters of the spiked meat with 95 μL of media were pre-incubated for 48 h in Vero cells. The cells were then transduced with Ad-CMV-GFP for 48 h, as described. GFP expression was quantified fluorometrically, with the plot showing relative fluorescence units (RFU). Error bars represent standard errors (<span class="html-italic">n</span> = 3).</p>
Full article ">
4365 KiB  
Article
Deletion and Gene Expression Analyses Define the Paxilline Biosynthetic Gene Cluster in Penicillium paxilli
by Barry Scott, Carolyn A. Young, Sanjay Saikia, Lisa K. McMillan, Brendon J. Monahan, Albert Koulman, Jonathan Astin, Carla J. Eaton, Andrea Bryant, Ruth E. Wrenn, Sarah C. Finch, Brian A. Tapper, Emily J. Parker and Geoffrey B. Jameson
Toxins 2013, 5(8), 1422-1446; https://doi.org/10.3390/toxins5081422 - 14 Aug 2013
Cited by 24 | Viewed by 10239
Abstract
The indole-diterpene paxilline is an abundant secondary metabolite synthesized by Penicillium paxilli. In total, 21 genes have been identified at the PAX locus of which six have been previously confirmed to have a functional role in paxilline biosynthesis. A combination of bioinformatics, [...] Read more.
The indole-diterpene paxilline is an abundant secondary metabolite synthesized by Penicillium paxilli. In total, 21 genes have been identified at the PAX locus of which six have been previously confirmed to have a functional role in paxilline biosynthesis. A combination of bioinformatics, gene expression and targeted gene replacement analyses were used to define the boundaries of the PAX gene cluster. Targeted gene replacement identified seven genes, paxG, paxA, paxM, paxB, paxC, paxP and paxQ that were all required for paxilline production, with one additional gene, paxD, required for regular prenylation of the indole ring post paxilline synthesis. The two putative transcription factors, PP104 and PP105, were not co-regulated with the pax genes and based on targeted gene replacement, including the double knockout, did not have a role in paxilline production. The relationship of indole dimethylallyl transferases involved in prenylation of indole-diterpenes such as paxilline or lolitrem B, can be found as two disparate clades, not supported by prenylation type (e.g., regular or reverse). This paper provides insight into the P. paxilli indole-diterpene locus and reviews the recent advances identified in paxilline biosynthesis. Full article
Show Figures

Figure 1

Figure 1
<p>Proposed pathway for biosynthesis of paxilline and post-paxilline derivatives in <span class="html-italic">P. paxilli</span> based on experiments described here and in the recent work of Tagami <span class="html-italic">et al</span>. [<a href="#B12-toxins-05-01422" class="html-bibr">12</a>] and Liu <span class="html-italic">et al.</span> [<a href="#B13-toxins-05-01422" class="html-bibr">13</a>].</p>
Full article ">Figure 2
<p>Paxilline biosynthesis gene replacements. (<b>a</b>) Physical maps of <span class="html-italic">P. paxilli</span> wild-type genomic region, linear replacement construct and mutant allele for each of <span class="html-italic">paxA</span> (<span class="html-italic">PP114</span>), <span class="html-italic">paxM</span> (<span class="html-italic">PP115</span>), <span class="html-italic">paxB</span> (<span class="html-italic">PP116</span>), <span class="html-italic">paxC</span> (<span class="html-italic">PP117</span>) and <span class="html-italic">paxD</span> (<span class="html-italic">PP120</span>); (<b>b</b>) Autoradiographs of Southern blots of 1 μg genomic digest of <span class="html-italic">P. paxilli</span> wild-type and mutant alleles, probed with [<sup>32</sup>P] dCTP-labeled replacement construct for each gene.</p>
Full article ">Figure 3
<p>Deletion analysis of the paxilline biosynthesis gene cluster. (<b>a</b>) The <span class="html-italic">P. paxilli PAX</span> locus showing the organization of genes and ORFs. <span class="html-italic">Closed</span> arrows indicate the direction of gene/ORF transcription. The genes shown to be involved in paxilline and prenylated paxilline biosynthesis are designated as <span class="html-italic">pax</span> and the other predicted genes as <span class="html-italic">PP</span> (<span class="html-italic">Penicillium paxilli</span>). The <span class="html-italic">thin</span> red or green lines under the <span class="html-italic">PAX</span> locus indicate the deleted region for each gene or as an arrow in the case of the mutant CYD-67 that extends beyond the genomic region shown. Color scheme depicts role in paxilline biosynthesis based on gene deletion analysis: <span class="html-italic">red</span>—known role in paxilline biosynthesis; <span class="html-italic">green</span>—no role in paxilline biosynthesis, but <span class="html-italic">paxD</span> has a role in post-paxilline biosynthesis; (<b>b</b>) Normal phase TLC analysis for paxilline production in the <span class="html-italic">P. paxilli</span> strains deleted for the genes/ORFs mentioned in panel A. For paxilline extraction, mycelium was harvested 6 days after inoculation. Abbreviations: 13-dp, 13-desoxypaxilline; pasp, paspaline; pax, paxilline.</p>
Full article ">Figure 4
<p>Alignment of predicted amino acid sequences for PaxC and related prenyltransferases. Numbers indicate the position of the last amino acid residue displayed. Sequences are grouped into I (PaxC-related, prenyl transferases) and II (geranylgeranyl diphosphate synthases). The aspartate-rich motifs are indicated by <span class="html-italic">bold</span> lines above the sequences. Sequences include genes from <span class="html-italic">Penicillium paxilli</span> (Pp_PaxC, AAK11529 and Pp_PaxG, AAK11531), <span class="html-italic">P. chrysogenum</span> (Pc_XP_002562743), <span class="html-italic">Aspergillus clavatus</span> (Ac_XP_001273516), <span class="html-italic">A. niger</span> (An_XP_001394251), <span class="html-italic">A. flavus</span> (Af_AtmC AAT65718 and Af_AtmG AAT65717), <span class="html-italic">A. oryzae</span> (Ao_XP_001824349), <span class="html-italic">Neotyphodium lolii</span> (Nl_LtmC, ABF20225.1 and Nl_LtmG, AAW88510) and <span class="html-italic">Fusarium fujikuroi</span> (Ff_Ggs2, CAA75568.1).</p>
Full article ">Figure 5
<p>Alignment of amino acid sequences for PaxM and related FAD-dependent monooxygenases. Sequences were aligned using ClustalW and Jalview. The conserved dinucleotide binding motif (DBM), as well as the ATG, GD and G-helix (*) motifs found in functionally characterized FAD-dependent monooxygenases are highlighted. Sequences include: <span class="html-italic">P. paxilli</span> FAD-dependent monooxygenase (PaxM, AAK11530.1), <span class="html-italic">A. nidulans</span> hypothetical (ANID_11206.1), <span class="html-italic">N. crassa</span> fruiting body maturation protein, Fbm-1 (NCU02925.7), <span class="html-italic">M. oryzae</span> hypothetical (MGG_02256.6), <span class="html-italic">Nicotiana plumbaginifolia</span> zeaxanthin epoxidase (X95732.1) <span class="html-italic">Pseudomonas putida</span> salicylate hydroxylase, NahG (AAA25897.1) and <span class="html-italic">Klebsiella pneumoniae</span> FAD-dependent urate hydroxylase, UpxO (A6T923/3rp8).</p>
Full article ">Figure 6
<p>(<b>a</b>) Putative membrane topology of PaxA as determined by TMHMM; (<b>b</b>) Alignment of predicted amino acid sequences for PaxA and related proteins from representative fungi within the Eurotiomycetes (Eu) and Sordariomycetes (So). The predicted transmembrane helices, as determined by TMHMM, are indicated by <span class="html-italic">red boxes</span>. Numbers indicate the position of the last amino acid residue displayed. The predicted transmembrane helices in PaxA are labelled I-VI in both panel A and B. Sequences from <span class="html-italic">P. paxilli</span> (Pp_PaxA ADO29933), <span class="html-italic">A. flavus</span> (Afl_AtmA CAP53940.1), <span class="html-italic">A. fumigatus</span> (Afu_XP_753659), <span class="html-italic">A. nidulans</span> (An_XP_681792), <span class="html-italic">P. chrysogenum</span> (Pc_CAP95856), <span class="html-italic">Gibberella zeae</span> (Gz_XP_384732) and <span class="html-italic">Magnaporthe oryzae</span> (MGG_07792) are shown.</p>
Full article ">Figure 7
<p>(<b>a</b>) Putative membrane topology of PaxB as determined by TMHMM; (<b>b</b>) Alignment of predicted amino acid sequences for PaxB and related proteins from representative fungi within the Eurotiomycetes (Eu) and Sordariomycetes (So). The predicted transmembrane helices, as determined by TMHMM, are indicated by <span class="html-italic">red boxes</span>. Numbers indicate the position of the last amino acid residue displayed. The predicted transmembrane helices in PaxB are labeled I-VII in both panel A and B. Sequences are from <span class="html-italic">P. paxilli</span> (Pp_PaxB, ADO29934), <span class="html-italic">A. flavus</span> (Afl_AtmB, CAP53939), <span class="html-italic">A. fumigatus</span> (Afu_XP_751270), <span class="html-italic">A. nidulans</span> (An_XP_681413), <span class="html-italic">P. chrysogenum</span> (Pc_CAP80269), <span class="html-italic">N. lolii</span> (Nl_LtmB, ABF20226), <span class="html-italic">G. zeae</span> (Gz_XP_384770), <span class="html-italic">N. crassa</span> (Nc_XP_958743) and <span class="html-italic">M. oryzae</span> (MGG_07412).</p>
Full article ">Figure 8
<p>Coordinate expression of the <span class="html-italic">pax</span> genes is correlated with the onset of paxilline biosynthesis. (<b>a</b>) Time course of paxilline biosynthesis. For paxilline extraction, wild-type mycelium was harvested between 24 and 132 h of inoculation at 12 h intervals; (<b>b</b>) Expression analysis of <span class="html-italic">pax</span> genes. Total RNA was isolated from wild-type mycelium for each time point and used for cDNA synthesis. RT-PCR was performed with primers specific for each of the <span class="html-italic">pax</span> genes as well as the ORFs <span class="html-italic">PP111</span>, <span class="html-italic">PP112</span>, <span class="html-italic">PP121</span>, <span class="html-italic">PP122</span> and <span class="html-italic">tub2</span> (β-tubulin).</p>
Full article ">Figure 9
<p>LC-MS/MS analysis of <span class="html-italic">P. paxilli paxD</span> deletion mutant. (<b>a</b>) UV trace at 275 nm of extract of <span class="html-italic">P. paxilli</span> wild-type; (<b>b</b>) Single ion extracted (504.3 <span class="html-italic">m/z</span>) chromatograms for wild-type and <span class="html-italic">paxD</span> deletion mutant; (<b>c</b>) Collision-induced fragmentation spectrum of the 504.3 <span class="html-italic">m/z</span> ion from wild-type (average of 6 mass spectra). Key ions are 488.3 (loss of CH<sub>4</sub>), 486.3 (loss of H<sub>2</sub>O), which is similar to paxilline fragmentation and 198.2 (prenylated indole). Based on these spectra, we assume that the prenylation occurs on the indole part of the molecule. However, the exact location of the prenyl group on the indole system remains to be elucidated.</p>
Full article ">Figure 10
<p>Unrooted tree of PaxD and related dimethylallyl transferases connected with enzymatic functions. The alignment consisted of 752 amino acids of which 265 sites were informative. Protein IDs with associated GenBank accession numbers are provided in <a href="#toxins-05-01422-t003" class="html-table">Table A1</a> together with additional information on position and type of prenylation including name of the metabolite and reference.</p>
Full article ">
626 KiB  
Review
Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
by Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, Charlotte Menne Bonefeld, Mariusz A. Wasik, Sergei B. Koralov, Carsten Geisler, Mogens Kilian, Lars Iversen, Anders Woetmann and Niels Odum
Toxins 2013, 5(8), 1402-1421; https://doi.org/10.3390/toxins5081402 - 14 Aug 2013
Cited by 76 | Viewed by 10992
Abstract
In patients with cutaneous T-cell lymphoma (CTCL) bacterial infections constitute a major clinical problem caused by compromised skin barrier and a progressive immunodeficiency. Indeed, the majority of patients with advanced disease die from infections with bacteria, e.g., Staphylococcus aureus. Bacterial toxins such [...] Read more.
In patients with cutaneous T-cell lymphoma (CTCL) bacterial infections constitute a major clinical problem caused by compromised skin barrier and a progressive immunodeficiency. Indeed, the majority of patients with advanced disease die from infections with bacteria, e.g., Staphylococcus aureus. Bacterial toxins such as staphylococcal enterotoxins (SE) have long been suspected to be involved in the pathogenesis in CTCL. Here, we review links between bacterial infections and CTCL with focus on earlier studies addressing a direct role of SE on malignant T cells and recent data indicating novel indirect mechanisms involving SE- and cytokine-driven cross-talk between malignant- and non-malignant T cells. Full article
(This article belongs to the Special Issue Toxins and Carcinogenesis)
Show Figures

Figure 1

Figure 1
<p>Schematic illustration of the antigen presenting cells (APC) antigen presentation and cytokine release together with the subsequent induction of different lymphocyte helper subsets. (<b>1</b>) The APC delivers three signals required for successful lymphocyte activation; antigen presentation, co-stimulation and cytokine release with cytokines being the major determinant of lymphocyte subset induction; (<b>2</b>) Additionally dendritic cells DC are able to induce a regulatory phenotype either by the absence of co-stimulation (immature DC’s lack CD80/86) or by activation of lymphocytes in a regulatory cytokine environment (tolerogenic DC’s).</p>
Full article ">Figure 2
<p>Schematic illustration of the transition from a state of tumor equilibrium to a state of tumor immune privilege. The tumor equilibrium state (<b>1</b>) is characterized by T cell- and cytokine-mediated control of tumor progression. Conversely, the state of tumor immune privilege (<b>2</b>) is predominated by regulatory signals and cytokines allowing for immune evasion and tumor progression and metastasis. (Yellow: DC; blue: nonmalignant T cell; red: malignant T cell).</p>
Full article ">Figure 3
<p>Schematic illustration of SE-mediated cross-talk between malignant and non-malignant T cells. Malignant T cells often display deficient expression and function of the TCR/CD3 complex and may not respond directly to bacterial superantigens such as staphylococcal enterotoxins (SE). Instead, malignant T cells often express MHC class II molecules, which are high-affinity receptors for SE (<b>1</b>). Non-malignant T cells with the appropriate Vb TCR respond to SE presented by malignant T cells (<b>2</b>, <b>3</b>) or by antigen presenting cells (APC) (not shown). SE-mediated cross-talk between malignant and non-malignant T cells triggers cell-to-cell contact and production of growth factors, which in turn promote proliferation of malignant T cells (<b>3</b>) [<a href="#B104-toxins-05-01402" class="html-bibr">104</a>].</p>
Full article ">
917 KiB  
Review
Earthworm-Derived Pore-Forming Toxin Lysenin and Screening of Its Inhibitors
by Neelanun Sukumwang and Kazuo Umezawa
Toxins 2013, 5(8), 1392-1401; https://doi.org/10.3390/toxins5081392 - 8 Aug 2013
Cited by 17 | Viewed by 9612
Abstract
Lysenin is a pore-forming toxin from the coelomic fluid of earthworm Eisenia foetida. This protein specifically binds to sphingomyelin and induces erythrocyte lysis. Lysenin consists of 297 amino acids with a molecular weight of 41 kDa. We screened for cellular signal transduction [...] Read more.
Lysenin is a pore-forming toxin from the coelomic fluid of earthworm Eisenia foetida. This protein specifically binds to sphingomyelin and induces erythrocyte lysis. Lysenin consists of 297 amino acids with a molecular weight of 41 kDa. We screened for cellular signal transduction inhibitors of low molecular weight from microorganisms and plants. The purpose of the screening was to study the mechanism of diseases using the obtained inhibitors and to develop new chemotherapeutic agents acting in the new mechanism. Therefore, our aim was to screen for inhibitors of Lysenin-induced hemolysis from plant extracts and microbial culture filtrates. As a result, we isolated all-E-lutein from an extract of Dalbergia latifolia leaves. All-E-lutein is likely to inhibit the process of Lysenin-membrane binding and/or oligomer formation rather than pore formation. Additionally, we isolated tyrosylproline anhydride from the culture filtrate of Streptomyces as an inhibitor of Lysenin-induced hemolysis. Full article
(This article belongs to the Special Issue Pore-Forming Toxins)
Show Figures

Figure 1

Figure 1
<p>Earthworm <span class="html-italic">Eisenia foetida</span> ejecting coelomic fluid.</p>
Full article ">Figure 2
<p>Pore formation by Lysenin.</p>
Full article ">Figure 3
<p>(<b>A</b>) All-<span class="html-italic">E</span>-Lutein; (<b>B</b>) All-<span class="html-italic">E</span>-lutein-producing plant <span class="html-italic">Dalbergia latifolia</span>. It belongs to the family of <span class="html-italic">Fabaceae</span> (<span class="html-italic">Leguminosae</span>), and is commonly called East Indian rosewood or black rosewood</p>
Full article ">Figure 4
<p>(<b>A</b>) Induction of hemolysis by Lysenin in sheep red blood cells; (<b>B</b>) Inhibition of Lysenin-induced hemolysis by all-<span class="html-italic">E</span>-lutein. PEG 4000 and dextran 4 are known inhibitors of hemolysis; (<b>C</b>) All-<span class="html-italic">E</span>-lutein does not inhibit polyoxypeptin A-induced hemolysis. The Data are mean ± S.D. of experiment performed in triplicate. (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 5
<p>(<b>A</b>) Tyrosylproline anhydride; (<b>B</b>) Inhibition of Lysenin-induced hemolysis by tyrosylproline anhydride; (<b>C</b>) Neither tyrosine nor proline inhibits Lysenin-induced hemolysis. The Data are mean ± S.D. of experiment performed in triplicate. (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01)</p>
Full article ">
604 KiB  
Article
A Label Free Colorimetric Assay for the Detection of Active Botulinum Neurotoxin Type A by SNAP-25 Conjugated Colloidal Gold
by Jennifer Halliwell and Christopher Gwenin
Toxins 2013, 5(8), 1381-1391; https://doi.org/10.3390/toxins5081381 - 6 Aug 2013
Cited by 15 | Viewed by 8120
Abstract
Botulinum neurotoxins are one of the most potent toxins known to man. Current methods of detection involve the quantification of the toxin but do not take into account the percentage of the toxin that is active. At present the assay used for monitoring [...] Read more.
Botulinum neurotoxins are one of the most potent toxins known to man. Current methods of detection involve the quantification of the toxin but do not take into account the percentage of the toxin that is active. At present the assay used for monitoring the activity of the toxin is the mouse bioassay, which is lengthy and has ethical issues due to the use of live animals. This report demonstrates a novel assay that utilises the endopeptidase activity of the toxin to detect Botulinum neurotoxin in a pharmaceutical sample. The cleaving of SNAP-25 is monitored via UV-Visible spectroscopy with a limit of detection of 373 fg/mL and has been further developed into a high throughput method using a microplate reader detecting down to 600 fg/mL of active toxin. The results show clear differences between the toxin product and the placebo, which contains the pharmaceutical excipients human serum albumin and lactose, showing that the assay detects the active form of the toxin. Full article
(This article belongs to the Special Issue Advances in Toxin Detection)
Show Figures

Figure 1

Figure 1
<p>UV-Visible Spectroscopy showing uncoated (<b>left</b>) and coated (<b>right</b>) gold colloids (GC) and the addition of salt causing aggregation of the uncoated particles and cuvette images showing the visible colour change.</p>
Full article ">Figure 2
<p>Difference in change in absorbance at 630 and 525 nm on addition of salt with concentration of SNAP-25. (Insert) surface covered with 0.5 µg/mL of SNAP-25 at different pH values. Errors calculated to ± 1SD.</p>
Full article ">Figure 3
<p>SDS-PAGE gel showing cleaved and whole SNAP-25.</p>
Full article ">Figure 4
<p>UV-Visible Spectrum of SNAP-25 coated gold colloids (SGC) incubated with 1 pg/mL botulinum neurotoxin before NaCl was added and incubated for five minutes.</p>
Full article ">Figure 5
<p>Correlation graph showing difference in change in absorbance at 630 and 525 nm for a range of Botulinum Neurotoxin concentrations using the UV-Visible Spectrometer. Errors calculated to ± 1SD.</p>
Full article ">Figure 6
<p>Correlation graph showing difference in change in absorbance at 630 and 492 nm for a range of Botulinum Neurotoxin concentrations using the microplate reader. Errors calculated to ± 1SD.</p>
Full article ">
2208 KiB  
Review
pH-Triggered Conformational Switching along the Membrane Insertion Pathway of the Diphtheria Toxin T-Domain
by Alexey S. Ladokhin
Toxins 2013, 5(8), 1362-1380; https://doi.org/10.3390/toxins5081362 - 6 Aug 2013
Cited by 54 | Viewed by 12501
Abstract
The translocation (T)-domain plays a key role in the action of diphtheria toxin and is responsible for transferring the catalytic domain across the endosomal membrane into the cytosol in response to acidification. Deciphering the molecular mechanism of pH-dependent refolding and membrane insertion of [...] Read more.
The translocation (T)-domain plays a key role in the action of diphtheria toxin and is responsible for transferring the catalytic domain across the endosomal membrane into the cytosol in response to acidification. Deciphering the molecular mechanism of pH-dependent refolding and membrane insertion of the T-domain, which is considered to be a paradigm for cell entry of other bacterial toxins, reveals general physicochemical principles underlying membrane protein assembly and signaling on membrane interfaces. Structure-function studies along the T-domain insertion pathway have been affected by the presence of multiple conformations at the same time, which hinders the application of high-resolution structural techniques. Here, we review recent progress in structural, functional and thermodynamic studies of the T-domain archived using a combination of site-selective fluorescence labeling with an array of spectroscopic techniques and computer simulations. We also discuss the principles of conformational switching along the insertion pathway revealed by studies of a series of T-domain mutants with substitutions of histidine residues. Full article
(This article belongs to the Special Issue Diphtheria Toxin)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Schematic representation of the endosomal pathway of cellular entry of diphtheria toxin, DT (adapted from [<a href="#B1-toxins-05-01362" class="html-bibr">1</a>]). The toxin consists of three domains: receptor-binding (R) domain, responsible for initiating endocytosis by binding to the heparin-binding EGF (epidermal growth factor)-like receptor; translocation (T)-domain; and catalytic (C)-domain, blocking protein synthesis via modification of elongation factor 2. This review is concerned with pH-triggered conformational change of the T-domain resulting in refolding, membrane insertion and translocation of the C-domain (highlighted by the red rectangle).</p>
Full article ">Figure 2
<p>(<b>A</b>) Backbone ribbon representation of the crystallographic structure of the T-domain [<a href="#B18-toxins-05-01362" class="html-bibr">18</a>]. Histidine 257 (red), critical for pH-triggered refolding [<a href="#B27-toxins-05-01362" class="html-bibr">27</a>], is positioned between helices TH1-2 (yellow) and TH3-4 (blue). Other regions of the protein are: consensus membrane insertion domain, TH8-9, in brown and helices TH6-7 in grey. Two tryptophan residues are shown as space-filling models: W206 in yellow and W281 in grey. Lower panel (<b>B</b>) represents another view of the region surrounding H257, including H223 (purple), suggested to act as a safety latch preventing premature unfolding by modulating protonation of H257 [<a href="#B28-toxins-05-01362" class="html-bibr">28</a>].</p>
Full article ">Figure 3
<p>Schematic representation of the pH-dependent membrane insertion pathway of the diphtheria toxin T-domain (modified from [<a href="#B26-toxins-05-01362" class="html-bibr">26</a>]). Initial protonation, resulting in conversion of membrane-incompetent W-state to membrane-competent W<sup>+</sup>-state, occurs primarily in the bulk of the solution. In the presence of membranes, this state rapidly associates with the bilayer to form an interfacial intermediate I-state. Subsequent insertion is facilitated by the presence of anionic lipids, which promote the formation of the insertion-competent I<sup>+</sup>-state and decrease the thermodynamic barrier for insertion into the TH8-9 helical hairpin. The two protonation steps responsible for the formation of conformations capable of membrane association (W-to-W<sup>+</sup> transition, red rectangle) and insertion (I-to-I<sup>+</sup> transition, blue rectangle) have overlapping pH ranges, suggesting that additional protonation can occur at the same pH value, due to the shift of pKa values of titratable residues after their partitioning into the interfacial zone of the lipid bilayer. While the structure of the functional state of the T-domain on the membrane remains unknown, experimental evidence suggests coexistence of multiple transmembrane (TM)-inserted states, possibly affected by pH and membrane potential (see text and <a href="#toxins-05-01362-f006" class="html-fig">Figure 6</a> [<a href="#B29-toxins-05-01362" class="html-bibr">29</a>]).</p>
Full article ">Figure 4
<p>pH-dependent conversion of the T-domain from the soluble W-state into the membrane-competent W<sup>+</sup>-state, identified through the following measurements of membrane binding at lipid saturation [<a href="#B26-toxins-05-01362" class="html-bibr">26</a>]: Fluorescence Correlation Spectroscopy-based mobility measurements (diamonds); measurements of FRET (Förster resonance energy transfer) between the donor-labeled T-domain and acceptor-labeled vesicles (circles). The solid line represents the global fit of the combined data [<a href="#B28-toxins-05-01362" class="html-bibr">28</a>].</p>
Full article ">Figure 5
<p>pH-dependent transmembrane (TM) insertion of the T-domain into the vesicles with various lipid compositions measured by fluorescence of the environment-sensitive probe, NBD (<span class="html-italic">N</span>-(7-nitro-2-1,3-benzoxadiazol-4-yl), attached to a single cysteine in the middle of TH9 helix [<a href="#B26-toxins-05-01362" class="html-bibr">26</a>]. Insertion is promoted by anionic lipids (molar ratios of POPC(palmitoyloleoylphosphatidylcholine)-to-POPG(palmitoyloleoylphosphatidyl­glycerol) three-to-one1 shown in red and one-to-three in blue). No TM insertion is observed when the POPC-to-POPG ratio is nine-to-one (green); even the protein is completely bound to the membrane in the interfacial I-state (<a href="#toxins-05-01362-f003" class="html-fig">Figure 3</a>). This lipid-dependent TM insertion is independently confirmed by topology experiments [<a href="#B26-toxins-05-01362" class="html-bibr">26</a>] based on the fluorescence lifetime quenching method [<a href="#B44-toxins-05-01362" class="html-bibr">44</a>].</p>
Full article ">Figure 6
<p>Role of C-terminal histidines in modulating membrane-insertion pathway of the T-domain [<a href="#B29-toxins-05-01362" class="html-bibr">29</a>,<a href="#B42-toxins-05-01362" class="html-bibr">42</a>]. (<b>A</b>) <span class="html-italic">C</span>-terminal histidines, H322, H323 and H372, are located on top of the insertion unit comprising a helical hairpin TH8-9 (highlighted in brown) in the crystal structure of the soluble form of the diphtheria toxin T-domain. Tryptophan residues W206 and W281 are shown in yellow, and the rest of the protein is shown in grey; (<b>B</b>) Schematic representation of the differences in the insertion process of the WT T-domain and its mutants. Top (WT T-domain): upon initial destabilization of the WT T-domain and its association with the lipid bilayer, the <span class="html-italic">N</span>-terminal region of the protein adopts a conformation that leads to the insertion of the TH8-9 unit into the bilayer. The <span class="html-italic">N</span>-terminal region refolds to form the open channel state (OCS). Bottom (mutants with <span class="html-italic">C</span>-terminal histidine replacements): membrane interaction of these mutants results in a different conformation from that of the WT, specifically in the more exposed <span class="html-italic">N</span>-terminal part, as revealed by a red-shifted fluorescence. While the initial insertion of TH8-9 is not compromised by the mutations [<a href="#B42-toxins-05-01362" class="html-bibr">42</a>], the replacement of <span class="html-italic">C</span>-terminal histidines, especially that of H322, affects efficient folding of the T-domain into the OCS [<a href="#B29-toxins-05-01362" class="html-bibr">29</a>].</p>
Full article ">Figure 7
<p>pKa distributions for <span class="html-italic">N</span>-terminal (<b>a</b>,<b>c</b>) and <span class="html-italic">C</span>-terminal (<b>b</b>,<b>d</b>) histidine residues of the T-domain calculated in Poisson-Boltzmann approximation from Molecular Dynamics (MD) traces for the membrane-incompetent W-state (a,b) and the membrane-competent W<sup>+</sup>-state (c,d) (data for the entire MD trace are published in [<a href="#B28-toxins-05-01362" class="html-bibr">28</a>]). Remarkably, the only two residues with bimodal distribution of pKa are those that were shown to be critical to refolding in solution (H257) and to guiding the insertion from the membrane interface (H322) by mutagenesis studies [<a href="#B27-toxins-05-01362" class="html-bibr">27</a>,<a href="#B29-toxins-05-01362" class="html-bibr">29</a>]. Note that under conditions of endosomal pH, all six histidines are predicted to be protonated in the W<sup>+</sup>-state. Coupling of histidine protonation to the conformational change results in a complete conversion of the T-domain to the membrane-competent state by pH 5.5, which is observed experimentally (<a href="#toxins-05-01362-f004" class="html-fig">Figure 4</a>).</p>
Full article ">
383 KiB  
Communication
Occurrence of Deoxynivalenol in Wheat in Slovakia during 2010 and 2011
by Svetlana Šliková, Soňa Gavurníková, Valéria Šudyová and Edita Gregová
Toxins 2013, 5(8), 1353-1361; https://doi.org/10.3390/toxins5081353 - 2 Aug 2013
Cited by 18 | Viewed by 5752
Abstract
In this study, a total of 299 grain samples of wheat were collected from four production regions: the maize, sugar beet, potato and feed sectors of Slovakia. The samples were analyzed for deoxynivalenol (DON) content by using an enzyme-linked immunosorbent assay Ridascreen® [...] Read more.
In this study, a total of 299 grain samples of wheat were collected from four production regions: the maize, sugar beet, potato and feed sectors of Slovakia. The samples were analyzed for deoxynivalenol (DON) content by using an enzyme-linked immunosorbent assay Ridascreen® Fast DON. Analysis of variance revealed a significant difference between years in DON contents (p < 0.027). The occurrence of samples with DON was 82.2% in 2010, with maximum DON content of 7.88 mg kg?1, and 70.7% in 2011, with maximum DON content of 2.12 mg·kg?1. The total mean DON content was 0.62 mg·kg?1; in the feed region 0.22 mg·kg?1; 0.63 mg·kg?1 in the maize region; 0.78 mg·kg?1 in the sugar beet region; 0.45 mg·kg?1 the potato region. The limit of 1.25 mg·kg?1 imposed by the European Union (EU) for DON content was exceeded in 13.7% of the studied samples. The average monthly rainfall for May to June played a critical role in DON content of wheat grains for maize and sugar beet producing regions. The present results indicate that DON content was at a high level in grains from wheat grown during 2010. Full article
283 KiB  
Review
Clinical Marine Toxicology: A European Perspective for Clinical Toxicologists and Poison Centers
by Corinne Schmitt and Luc De Haro
Toxins 2013, 5(8), 1343-1352; https://doi.org/10.3390/toxins5081343 - 2 Aug 2013
Cited by 21 | Viewed by 7421
Abstract
Clinical marine toxicology is a rapidly changing area. Many of the new discoveries reported every year in Europe involve ecological disturbances—including global warming—that have induced modifications in the chorology, behavior, and toxicity of many species of venomous or poisonous aquatic life including algae, [...] Read more.
Clinical marine toxicology is a rapidly changing area. Many of the new discoveries reported every year in Europe involve ecological disturbances—including global warming—that have induced modifications in the chorology, behavior, and toxicity of many species of venomous or poisonous aquatic life including algae, ascidians, fish and shellfish. These changes have raised a number of public issues associated, e.g., poisoning after ingestion of contaminated seafood, envenomation by fish stings, and exposure to harmful microorganism blooms. The purpose of this review of medical and scientific literature in marine toxicology is to highlight the growing challenges induced by ecological disturbances that confront clinical toxicologists during the everyday job in the European Poison Centers. Full article
(This article belongs to the Collection Marine and Freshwater Toxins)
667 KiB  
Article
The Effects of a Chactoid Scorpion Venom and Its Purified Toxins on Rat Blood Pressure and Mast Cells Histamine Release
by Keren Ettinger, Gadi Cohen, Tatjana Momic and Philip Lazarovici
Toxins 2013, 5(8), 1332-1342; https://doi.org/10.3390/toxins5081332 - 29 Jul 2013
Cited by 4 | Viewed by 6597
Abstract
The effect of the venom of the Chactoid family of scorpions on blood pressure was scantly investigated and was addressed in the present study using the venom of the Israeli scorpion, Scorpio maurus palmatus. Blood pressure in rats was monitored via cannulated [...] Read more.
The effect of the venom of the Chactoid family of scorpions on blood pressure was scantly investigated and was addressed in the present study using the venom of the Israeli scorpion, Scorpio maurus palmatus. Blood pressure in rats was monitored via cannulated femoral artery, while venom and toxins were introduced into femoral vein. Venom injection elicited a biphasic effect, expressed first by a fast and transient hypotensive response, which lasted up to 10 min, followed by a hypertensive response, which lasted up to one hour. It was found that these effects resulted from different venom components. Phospholipase A2 produced the hypotensive effect, while a non-enzymatic neurotoxic polypeptide fraction produced the hypertensive effect. Surprisingly, the main neurotoxic polypeptide to mice had no effect on blood pressure. In vitro experiments indicated that the hypertensive factors caused histamine release from the peritoneal mast cells, but this effect is assumed to be not relevant to their in vivo effect. In spite of the cytotoxic activity of phospholipase A2, it did not release histamine. These findings suggest that the effects of venom and isolated fractions on blood pressure parameters are mediated by different mechanisms, which deserve further pharmacological investigation. Full article
(This article belongs to the Special Issue Scorpion Toxins 2013)
Show Figures

Figure 1

Figure 1
<p>The typical effect of <span class="html-italic">Scorpio maurus palmatus</span> venom on blood pressure. The original tracing of the experiments show the blood pressure response (mm Hg) after addition of different doses of venom indicated by the vertical arrow. Each trace represents a single rat receiving a single dose of venom (representing measurements of eight rats). The length of the horizontal lines represents the time course of the experiment: thin line (sec); thick line (min).</p>
Full article ">Figure 2
<p>Gel filtration chromatography of <span class="html-italic">Scorpio maurus palmatus</span> venom. 500 mg of venom were separated on Sephadex G-50 gel equilibrated and eluted by 0.1 M ammonium acetate, pH 8.5. The flow rate was 15 mL/h, and fractions of 10 mL were collected. The marked areas correspond to PlA<sub>2</sub> and neurotoxic fractions, respectively. Full circles represent protein absorbance at 280 nm, and open circles correspond to the PlA<sub>2</sub> activity.</p>
Full article ">Figure 3
<p>The effect on blood pressure of <span class="html-italic">Scorpio maurus palmatus</span> venom protein fractions isolated by gel permeation and purified toxins. (<b>A</b>) Neurotoxins effect on blood pressure; (<b>B</b>) PlA<sub>2</sub> effect on blood pressure; (<b>C</b>) reconstitution of whole venom effect and synergistic effect on blood pressure of mixed doses of neurotoxin and PlA<sub>2</sub> at different protein ratios. Each trace represents a single rat receiving a single dose of tested compound (representing measurements of 6–8 rats). The length of the horizontal lines represents the time course of the experiment: thin line (sec); thick line (min).</p>
Full article ">Figure 4
<p>The effect of <span class="html-italic">Scorpio maurus palmatus</span> venom and protein fractions isolated by gel permeation and purified toxins on histamine release <span class="html-italic">in vitro</span> from mast cells.</p>
Full article ">
Previous Issue
Next Issue
Back to TopTop